HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

CGS-19755, a competitive NMDA receptor antagonist, reduces calcium-calmodulin binding and improves outcome after global cerebral ischemia.

Abstract
We evaluated several doses of cis-4-(phosphonomethyl)-2-piperidine-carboxylic acid (CGS-19755), a potent competitive N-methyl-D-aspartate (NMDA) receptor antagonist, systemically administered either before or after 20 to 30 minutes of global ischemia in rats. We measured outcome by mortality, histological damage by light microscopy, and learning ability on an eight-arm maze, and determined the drug's mechanism of action by an immunohistochemical assay of calcium-calmodulin binding. High-dose treatment begun prior to ischemia resulted in reduced cellular damage in severely ischemic hippocampal tissue, but also caused high mortality due to respiratory depression. Treatment begun 30 minutes after ischemia resulted in little histological protection but significantly improved learning ability when tested 1 month after ischemia, and did not increase mortality. Furthermore, CGS-19755, 10 mg/kg intraperitoneally, begun either before or after ischemia substantially reduced calcium influx into ischemic neurons as evidenced by reduced calcium-calmodulin binding. We conclude that CGS-19755 prevents calcium entry into ischemic neurons and may be effective therapy for very acute cerebral ischemia.
AuthorsJ C Grotta, C M Picone, P T Ostrow, R A Strong, R M Earls, L P Yao, H M Rhoades, J R Dedman
JournalAnnals of neurology (Ann Neurol) Vol. 27 Issue 6 Pg. 612-9 (Jun 1990) ISSN: 0364-5134 [Print] United States
PMID2163237 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Calmodulin
  • Pipecolic Acids
  • Piperidines
  • Receptors, N-Methyl-D-Aspartate
  • Receptors, Neurotransmitter
  • selfotel
  • Calcium
Topics
  • Animals
  • Calcium (metabolism)
  • Calmodulin (metabolism)
  • Dose-Response Relationship, Drug
  • Ischemic Attack, Transient (drug therapy, metabolism, mortality)
  • Male
  • Pipecolic Acids
  • Piperidines (pharmacology, therapeutic use)
  • Rats
  • Rats, Inbred Strains
  • Receptors, N-Methyl-D-Aspartate
  • Receptors, Neurotransmitter (drug effects, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: